NCODA’s Oncology & Hematology Meeting Abstracts (NOHMA)

Editor-in-Chief
Jonathan Rivera, PharmD, Bala Cynwyd, PA

Editorial Team
Assistant Editor
Daisy Doan, PharmD, Dallas, TX

Editorial Fellows
Madelyn Floysand, PharmD, Denver, CO
Shawnny Eugene, PharmD, MBA, MS, Fort Lauderdale, FL

Production Team
Production Editors
Anthony Woodard, St. Petersburg, FL
Paul Farhat, Chicago, IL

The NCODA Oncology and Hematology Meeting Abstracts (NOHMA) publishes peer-review meeting abstract content presented at NCODA meetings. Meeting abstracts are published as supplements to provide a
permanent scholarly record of accepted presentations and must align with NCODA’s mission to support medically integrated oncology teams through leadership, expertise, quality standards, best practices, and a
focus on positive, patient-centered outcomes.

Authors are required to disclose all financial and personal relationships that may influence or be perceived to influence their work. Authors must also disclose whether the abstract represents an encore presentation and identifies the meeting or venue where the work was previously presented.

Abstracts describing ongoing or incomplete research must be clearly designated as trial in progress or equivalent at the time of submission and publication.

Product trade names are generally used only at the first reference to the generic name. Use of trade and generic naming conventions may be adjusted at the editor’s discretion to enhance clarity and consistency.

All meeting abstracts underwent peer review for scientific rigor, relevance, and clarity. Independent acceptance recommendations were provided, and final publication decisions were made by the editorial team and Editor-in-Chief. The Editor-in-Chief reserves the right to reject supplement submissions before or after peer review.

Peer Reviewers
Mary K. Anderson, BSN, RN, OCN
Mustafa Abacioglu, MPharm
Natasha Olson, PharmD
Taryn Newsome, CPhT

The views expressed in these meeting abstracts are those of the authors and do not necessarily reflect the official policies or positions of NCODA or its affiliated institutions. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without permission from NCODA.

Readers are advised to consult the appropriate medical literature and product information provided by the manufacturer of each drug to be administered to verify dosage, method and duration of administration, and contraindications. It is the responsibility of the treating physician or other healthcare professionals, relying on independent experience and knowledge of the patient, to determine the most appropriate treatment.